Clinical trial
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing…
NCT00209430 · GE Healthcare, Industry · Completed
Key facts
| NCT number | NCT00209430 |
|---|---|
| Title | Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography |
| Official title | GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title. |
| Lead sponsor | GE Healthcare, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Renal Impairment |
| Intervention type | Drug |
| Interventions | Iodixanol 320 mgI/mL |
| Enrollment | 408 |
| Start date | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 31, 2007 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: